Burning Rock Biotech Ltd
BNR30.690USD
-3.310-9.74%
收盘 02/09, 16:00（美东）报价延迟15分钟
277.10M总市值
亏损市盈率 TTM
关于 Burning Rock Biotech Ltd 公司
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Burning Rock Biotech Ltd简介
公司代码BNR
公司名称Burning Rock Biotech Ltd
上市日期Jun 12, 2020
CEOHan (Yusheng)
员工数量674
证券类型Depository Receipt
年结日Jun 12
公司地址No. 5 Xingdao Ring Road North
城市GUANGZHOU
上市交易所NASDAQ OMX - NASDAQ BASIC
国家China
邮编510005
电话
网址https://www.brbiotech.com/
公司代码BNR
上市日期Jun 12, 2020
CEOHan (Yusheng)
Burning Rock Biotech Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Yusheng Han
Mr. Yusheng Han
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Gang Lu
Mr. Gang Lu
Director
Director
--
--
Mr. Feng Deng
Mr. Feng Deng
Director
Director
--
--
Ms. Wendy Hayes, CPA
Ms. Wendy Hayes, CPA
Independent Director
Independent Director
--
--
Dr. Zhihong (Joe) Zhang, Ph.D.
Dr. Zhihong (Joe) Zhang, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Lisa (Licen) Xu
Dr. Lisa (Licen) Xu
Independent Director
Independent Director
--
--
Ms. Xiaozhi Hu
Ms. Xiaozhi Hu
Senior Director in Finance
Senior Director in Finance
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Yusheng Han
Mr. Yusheng Han
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Gang Lu
Mr. Gang Lu
Director
Director
--
--
Mr. Feng Deng
Mr. Feng Deng
Director
Director
--
--
Ms. Wendy Hayes, CPA
Ms. Wendy Hayes, CPA
Independent Director
Independent Director
--
--
Dr. Zhihong (Joe) Zhang, Ph.D.
Dr. Zhihong (Joe) Zhang, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Lisa (Licen) Xu
Dr. Lisa (Licen) Xu
Independent Director
Independent Director
--
--
收入明细
FY2019
FY2018
由于公司未披露，未能获取相关数据
地区USD
名称
营收
占比
China (Mainland)
0.00
0.00%
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 2月4日 周三
更新时间: 2月4日 周三
持股股东
股东类型
持股股东
持股股东
占比
Northern Light Venture Capital
11.68%
Kynam Capital Management LP
11.02%
Lyfe Capital
9.24%
CRCM L.P.
5.39%
China Merchants Bank Co Ltd
5.13%
其他
57.55%
持股股东
持股股东
占比
Northern Light Venture Capital
11.68%
Kynam Capital Management LP
11.02%
Lyfe Capital
9.24%
CRCM L.P.
5.39%
China Merchants Bank Co Ltd
5.13%
其他
57.55%
股东类型
持股股东
占比
Private Equity
20.91%
Hedge Fund
11.37%
Investment Advisor/Hedge Fund
6.30%
Bank and Trust
5.14%
Corporation
3.92%
Investment Advisor
0.93%
Research Firm
0.58%
其他
50.86%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
39
4.08M
45.22%
-131.84K
2025Q3
49
4.65M
47.27%
-5.46K
2025Q2
58
4.65M
51.33%
-759.34K
2025Q1
65
5.41M
53.38%
+589.94K
2024Q4
74
5.54M
50.70%
+348.38K
2024Q3
93
5.26M
57.60%
-7.02K
2024Q2
108
5.27M
61.36%
-5.69K
2024Q1
121
5.30M
64.27%
-181.25K
2023Q4
137
5.23M
65.24%
+745.66K
2023Q3
205
5.00M
74.63%
-61.48K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Northern Light Venture Capital
1.05M
11.68%
--
--
Mar 31, 2025
Kynam Capital Management LP
994.88K
11.02%
--
--
Sep 30, 2025
Lyfe Capital
833.84K
9.24%
--
--
Mar 31, 2025
CRCM L.P.
486.43K
5.39%
+264.85K
+119.53%
Dec 16, 2025
China Merchants Bank Co Ltd
462.99K
5.13%
--
--
Mar 31, 2025
Quantum Boundary Holdings Ltd
353.92K
3.92%
+350.62K
+10637.83%
Mar 31, 2025
Amova Asset Management Americas, Inc
45.55K
0.5%
+45.55K
--
Dec 31, 2024
Amova Asset Management Co., Ltd.
34.84K
0.39%
-9.09K
-20.68%
Sep 30, 2025
Renaissance Technologies LLC
31.72K
0.35%
--
--
Sep 30, 2025
Prospera Financial Services, Inc.
24.75K
0.27%
+24.75K
--
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Avantis Responsible Emerging Markets Equity ETF
0%
DFA Dimensional Emerging Markets Core Equity 2 ETF
0%
SPDR S&P Emerging Markets Small Cap ETF
0%
Avantis Responsible Emerging Markets Equity ETF
占比0%
DFA Dimensional Emerging Markets Core Equity 2 ETF
占比0%
SPDR S&P Emerging Markets Small Cap ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
公告日期
除权除息日
类型
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
